U.S. advisory panel clears an asthma drug
An advisory panel of the U.S. Food and Drug Administration has endorsed Genentech Inc.'s new asthma drug, the first biotechnology product for the disease. The panel by a vote of 11 to 0 agreed that
An advisory panel of the U.S. Food and Drug Administration has endorsed Genentech Inc.'s new asthma drug, the first biotechnology product for the disease. The panel by a vote of 11 to 0 agreed that